[2016BOA视频]周爱萍教授分享三项泌尿系统肿瘤重要研究

来源:医脉通 2016.07.20
我要投稿

2016年6月24-25日,临床肿瘤学新进展学术研讨会——Best of ASCO Event in China 2016在杭州召开。25日下午的泌尿系统肿瘤专场上,中国医学科学院院肿瘤医院主任医师周爱萍分享了三项泌尿系统肿瘤的重要研究报告。


三项研究摘要编号和题目:

Abstract 5001

A randomized phase III trial between adjuvant docetaxel and surveillance after radical prostatectomy for high risk prostate cancer: Results of SPCG12

 

Abstract 4506

Overall survival (OS) in METEOR, a randomized phase 3 trial of cabozantinib (Cabo) versus everolimus (Eve) in patients (pts) with advanced renal cell carcinoma (RCC).

 

Abstract LBA4500

Atezolizumab (atezo) as first-line (1L) therapy in cisplatinineligible locally advanced/metastatic urothelial carcinoma (mUC):Primary analysis of IMvigor210 cohort 1.


直通车:周芳坚教授对三项泌尿系统肿瘤重要研究进行评述


会议专题》》》2016临床肿瘤学新进展学术研讨会(BOA)